Selected data models

You must log in to select data models for download or further analysis.

2 Search results.
Relevance Rating New first Old first

Cisplatin and Topotecan Recurrent or Persistent Carcinoma of the Cervix - 103369 - Pre-Treatment Summary Sheet

- 3/14/19 - 1 form, 5 itemgroups, 41 items, 1 language
Itemgroups: Administrative data, Physical Examination, Laboratory Findings, Measurable Mass, Performance Grade
Study ID: 103369 Clinical Study ID: 103369 Study Title: A Randomized Phase III Study of Cisplatin Versus Cisplatin plus Topotecan Versus MVAC in Stage IVB, Recurrent or Persistent Squamous Cell Carcinoma of the Cervix Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: N/A Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 3 Study Recruitment Status: Completed Generic Name: Topotecan Trade Name: Topotecan Study Indication: Cancer 

Estimation of Dose Proportionality of Darapladib - 107038 - Repeated Visits: Pharmacodynamics Results - [Analyte and PD Sample Type]

- 11/13/18 - 1 form, 1 itemgroup, 3 items, 1 language
Itemgroup: Unscheduled Visit
Study ID: 107038 Clinical Study ID: LPL107038 Study Title: Study to Estimate the Dose Proportionality of the Enteric-Coated Freebase Formulation of SB-480848 Patient Level Data:  Clinicaltrials.gov Identifier:  Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 1 Study Recruitment Status: Completed Generic Name: darapladib Trade Name: Tyrisa ,US Study Indication: Atherosclerosis

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial